162 related articles for article (PubMed ID: 6787993)
1. Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma.
Venables PJ; Mumford PA; Maini RN
Ann Rheum Dis; 1981 Jun; 40(3):217-23. PubMed ID: 6787993
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
[TBL] [Abstract][Full Text] [Related]
3. [Spectrum of antinuclear and anti-cytoplasmic antibodies in dermatomyositis and polymyositis overlap syndromes].
Meurer M; Hausmann-Martinez-Pardo G; Braun-Falco O
Hautarzt; 1989 Oct; 40(10):623-9. PubMed ID: 2482267
[TBL] [Abstract][Full Text] [Related]
4. [The principle antinuclear and anti-cytoplasmic antibodies in polymyositis and dermatomyositis. Study of 42 cases].
Meyer O; Cremer-Legmann F; Haim T; Ryckewaert A
Presse Med; 1987 Feb; 16(4):155-8. PubMed ID: 2950445
[TBL] [Abstract][Full Text] [Related]
5. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antibody with distinct specificity for polymyositis.
Wolfe JF; Adelstein E; Sharp GC
J Clin Invest; 1977 Jan; 59(1):176-8. PubMed ID: 318657
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen.
Treadwell EL; Alspaugh MA; Wolfe JF; Sharp GC
J Rheumatol; 1984 Oct; 11(5):658-62. PubMed ID: 6334745
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.
Nishikai M; Reichlin M
Arthritis Rheum; 1980 Aug; 23(8):881-8. PubMed ID: 7406938
[TBL] [Abstract][Full Text] [Related]
9. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical associations of anti-Ku antibodies in systemic autoimmune diseases.
Cavazzana I; Ceribelli A; Quinzanini M; Scarsi M; Airò P; Cattaneo R; Franceschini F
Lupus; 2008 Aug; 17(8):727-32. PubMed ID: 18625650
[TBL] [Abstract][Full Text] [Related]
11. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.
Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C
Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751
[TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical characteristics of autoantibody systems in polymyositis and dermatomyositis.
Fudman EJ; Schnitzer TJ
Semin Arthritis Rheum; 1986 May; 15(4):255-60. PubMed ID: 3520822
[No Abstract] [Full Text] [Related]
13. An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.
Senécal JL; Isabelle C; Fritzler MJ; Targoff IN; Goldstein R; Gagné M; Raynauld JP; Joyal F; Troyanov Y; Dabauvalle MC
Medicine (Baltimore); 2014 Nov; 93(24):383-394. PubMed ID: 25500708
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis.
Chinoy H; Fertig N; Oddis CV; Ollier WE; Cooper RG
Ann Rheum Dis; 2007 Oct; 66(10):1345-9. PubMed ID: 17392346
[TBL] [Abstract][Full Text] [Related]
17. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in polymyositis.
Targoff IN
Rheum Dis Clin North Am; 1992 May; 18(2):455-82. PubMed ID: 1378227
[TBL] [Abstract][Full Text] [Related]
19. [Preliminary report on the clinical application of anti-Jo-1 antibody].
Dong Y; Cheng PC; Zhang NC
Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):368-9, 383. PubMed ID: 2582917
[TBL] [Abstract][Full Text] [Related]
20. [Antinuclear and anticytoplasmic antibodies in polymyositis and dermatomyositis].
Nishikai M; Sugimoto M; Sato A
Nihon Naika Gakkai Zasshi; 1986 Nov; 75(11):1597-601. PubMed ID: 3493313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
